Table 2.

Crude outcomes in hip fracture patients

	OFS 0		OFS 1		OFS 2		OFS 3		OFS 4		OFS 5
	BBt- (N = 20,003)	BBt+  (N = 10,460)	BBt- (N = 21,218)	BBt+  (N = 14,094)	BBt- (N = 20,113)	BBt+  (N = 13,685)	BBt- (N = 13,187)	BBt+  (N = 8,672)	BBt- (N = 2,831)	BBt+  (N = 2,597)	BBt- (N = 210)	BBt+  (N = 235)	p value
Length of stay, median [IQR]	7.0 [4.0–10]	8.0 [5.0–11]	9.0 [5.0–12]	9.0 [6.0–13]	8.0 [5.0–12]	9.0 [6.0–13]	7.0 [4.0–10]	8.0 [5.0–12]	6.0 [4.0–9.0]	7.0 [5.0–11]	6.0 [4.0–8.0]	6.0 [5.0–9.0]	< 0.001
Missing, n (%)	45 (0.2)	22 (0.2)	53 (0.2)	29 (0.2)	48 (0.2)	31 (0.2)	29 (0.2)	9 (0.1)	9 (0.3)	6 (0.2)	0 (0.0)	0 (0.0)
30-day mortality, n (%)	351 (1.8)	29 (0.3)	1325 (6.2)	175 (1.2)	2451 (12.2)	448 (3.3)	2420 (18.4)	726 (8.4)	873 (30.8)	381 (14.7)	88 (41.9)	40 (17.0)	< 0.001
Cardiovascular event, n (%)	143 (0.7)	13 (0.1)	485 (2.3)	72 (0.5)	954 (4.7)	193 (1.4)	992 (7.5)	325 (3.7)	379 (13.4)	197 (7.6)	43 (20.5)	16 (6.8)	< 0.001
Respiratory failure, n (%)	84 (0.4)	3 (0.0)	276 (1.3)	28 (0.2)	425 (2.1)	69 (0.5)	372 (2.8)	103 (1.2)	133 (4.7)	43 (1.7)	12 (5.7)	6 (2.6)	< 0.001
Cerebrovascular event, n (%)	7 (0.0)	2 (0.0)	28 (0.1)	5 (0.0)	34 (0.2)	10 (0.1)	38 (0.3)	7 (0.1)	9 (0.3)	4 (0.2)	1 (0.5)	0 (0.0)	< 0.001
Sepsis, n (%)	7 (0.0)	1 (0.0)	28 (0.1)	5 (0.0)	43 (0.2)	6 (0.0)	42 (0.3)	16 (0.2)	22 (0.8)	5 (0.2)	2 (1.0)	1 (0.4)	< 0.001
Multiorgan failure, n (%)	100 (0.5)	9 (0.1)	460 (2.2)	62 (0.4)	909 (4.5)	148 (1.1)	863 (6.5)	246 (2.8)	311 (11.0)	113 (4.4)	30 (14.3)	16 (6.8)	< 0.001
Unknown, n (%)	10 (0.0)	1 (0.0)	48 (0.2)	3 (0.0)	86 (0.4)	22 (0.2)	113 (0.9)	29 (0.3)	19 (0.7)	19 (0.7)	0 (0.0)	1 (0.4)	< 0.001

Length of stay is measured in days

OFS Orthopedic Hip Frailty Score, BBt- no beta-blocker therapy, BBt+, ongoing beta-blocker therapy